CTNM vs ULTA · $429.6M cap vs P/E 17, rev $3.04B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported ULTA revenue for 2026-08-01 was $3.04B. Net income was $282.0M. Revenue was down 4.1% from 2026-05-02 to 2026-08-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
CTNM currently screens at market cap $429.6M. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the CTNM and ULTA stock pages for the full models.
Not investment advice.